Introduction
Many heavy metals such as gold, 1-4 platinum, 5 bismuth, 6 silver, 7 tantalum, 8 tungsten, [9] [10] [11] [12] [13] and rare earth metals 14, 15 have been extensively studied as computed tomography (CT) contrast agents in an effort to replace the traditional iodine enhanced CT contrast agent, which generally requires a large injection dose and causes strong side effects. Recently, tungsten oxide nanoparticles (TONPs) were employed for CT imaging and photothermal therapy (PTT) due to their high X-ray attenuating potency and strong localized surface plasmon resonance (LSPR) properties. 16 Aerwards, Hu et al. synthesized ultrane W 18 O 49 NPs via a polyol method, which exhibited excellent water dispersity. 9 Compared with traditional PTT candidates (e.g., Au nanorods), W 18 O 49 NPs possess several advantages described as follows: (1) higher cost effectiveness and facile synthesis procedures that can be easily scaled up; (2) optimal size for lymphatic imaging (<10 nm) with respect to previously reported materials;
17 (3) the PTT of the NPs can be rendered via irradiation with a 1064 nm laser. The wavelength of the 1064 nm laser is long enough for deep skin penetration and high body tolerance. 18 Unfortunately, once exposed to air, W 18 O 49 NPs are quickly oxidized into various ions without strong LSPR properties. Furthermore, for renal failure patients, the in vivo formation of high osmotic pressure due to the ionic CT contrast agent can cause some adverse reactions. 19 Hence, there is a great need to fabricate W 18 O 49 NPs with excellent stability and water dispersibility, to be used as a CT agent and PTT agent in the clinic. Unfortunately, there has been little work related to the fabrication of W 18 O 49 NPs.
In this study, we synthesized W 18 O 49 @PEG-PCL NPs, which not only have the advantages of W 18 O 49 NPs, but also exhibit longer lasting stability. Furthermore, ve cycles of NIR laser irradiation was performed on the W 18 O 49 @PEG-PCL NPs and Au nanorods (the most common PTT agent), respectively. Compared with the Au nanorods, the W 18 O 49 @PEG-PCL NPs exhibited better photothermal conversion stability. Tumor tissue has a vascular system containing pores with sizes in the range of 20-500 nm, giving rise to a phenomenon known as the enhanced permeability and retention effect (EPR). [20] [21] [22] In vitro cellular uptake tests demonstrated that equipping W 18 O 49 with PEG-PCL can take advantage of EPR to implement the passive enrichment of NPs in the tumor location. An in vitro CT study and a cytotoxic assay revealed that W 18 O 49 @PEG-PCL NPs exhibit an excellent CT imaging effect, good biocompatibility and are suitable for in vivo applications. Eventually, the superior PTT potency of W 18 O 49 @PEG-PCL NPs will lead to their potential usage in the treatment of cancer.
other chemicals were purchased from J&K Chemicals and used as received without further treatment. Human ovarian cancer (HeLa) cells were obtained from Fudan University (Shanghai, China).
Synthesis of W 18 O 49
Based on a previous study, W 18 O 49 NPs can be synthesized by reducing WCl 6 with alcohol. 23 Here, we used diethylene glycol (DEG) as the solvent, because it is suitable for high temperature reactions. Briey, WCl 6 (800 mg) and PAA (200 mg) were dissolved in DEG (50 mL), and the suspension was heated at 160 C for 10 min and was then allowed to cool down to room temperature. Then deionized water (50 mL) was added into the mixture to induce precipitation. 
Synthesis of PEG-PCL
3-CL was mixed with a certain amount of m-PEG-OH, and the mixture was stirred at 160 C for 24 h in a vacuum-sealed tube.
Aer the polymerization was completed, the crude copolymers were dissolved in DCM and precipitated in an excess amount of cold ethyl ether to remove the unreacted monomer and oligomer. The precipitates were then ltered and dried under reduced pressure. were then separately introduced into the system for 2 h.
The medium was then discarded, and the cells were washed with PBS three times. Aer that, the cell nuclei and f-actin were stained with 4 0 ,6-diamidino-2-phenylindole (DAPI) and uo-rescein isothiocyanate (FITC) labeled phalloidine according to the manufacturer's instructions, respectively. Finally, the cells were xed with 4% paraformaldehyde and observed using a uorescence microscope (Carl Zeiss, Germany) equipped with an optiMOS CCD (Qimaging). Acquired uorescence images were further merged using ImageJ soware.
In vitro X-ray attenuation study (CT experiments)
Suspensions containing equivalent concentrations of W 18 O 49 NPs, W 18 O 49 @PEG-PCL and the clinical iodine contrast agent iodixanol (with respect to tungsten and iodine concentration: 6.25, 12.5, 25, 50, 100 mM) were added into a 48-well cell culture plate. CT images were collected using a clinical CT Gemstone spectral 64-Detector CT (Discovery CT 750HD, GE Amersham Healthcare System, Milwaukee, WI), and the images were acquired at an X-ray voltage of 65 kVp and an anode current of 500 mA.
In vitro cytotoxicity assay (MTT assay)
The cytotoxicity of the W 18 O 49 @PEG-PCL NPs was detected via a MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Briey, HeLa cells were seeded in 96-well plates at a density of 10 4 cells per well in 100 mL of Iscoves modied Dulbecco's medium and were incubated overnight at 37 C in a 5% CO 2 atmosphere. The medium of each well was replaced with 100 mL fresh medium containing various concentrations of the W 18 O 49 @PEG-PCL NPs. All concentrations were tested in ve replicates. Aer 24 h incubation (and then laser exposure at an energy density of 0.5 W cm À2 for 4 min or not) and 48 h incubation, the medium was aspirated, and the cells were washed twice with phosphate-buffered saline (PBS, pH 7.0), followed by the addition of 20 mL of MTT solution (2.5 mg mL À1 in PBS). The cells were then incubated for another 4 h at 37 C. Aer that, the medium was aspirated. The collected cells were resuspended in 200 mL DMSO, and the absorbance of each well at 490 nm was measured using an iMark Enzyme mark instrument (BIO-RAD Inc., USA). Table 1 .
Optical properties of the hybrid NPs
From the UV-vis spectra shown in Fig. 4A PCL NPs (Fig. 4C) Fig. 5D ) aer irradiation for 300 seconds at a concentration of 1 mg mL À1 under a 0.5 W cm À2 1064 nm laser, which is sufficient for cancer cell (Fig. 6) . From the UV spectra ( Fig. 6A  and) Fig. 6B ), the W 18 O 49 @PEG-PCL NPs clearly exhibit better photothermal conversion stability, because the W 18 O 49 NPs are uniformly spherical and in the most stable conformation, while the Au nanorods are club-shaped. Hyperthermia causes Au nanorods to become out of shape and they can be transformed from club-shaped to spherical-shaped (Fig. 6C) . Additionally, from Fig. 6D , we can nd that aer ve cycles, the elevation of the temperature of the W 18 O 49 @PEG-PCL NPs does not fade much compared to that of the Au nanorods. We selected the h full cycle, and the nal photothermal conversion efficiency (h) for the W 18 O 49 @PEG-PCL NPs and the Au nanorods was 65.8% and 16.8%, respectively. All these results show that our NPs can be superior over the Au nanorods. To explore the cytotoxicity of the W 18 O 49 @PEG-PCL NPs, the cellular uptake of W 18 O 49 @PEG-PCL NPs by HeLa cells was examined using a uorescent microscope (Fig. 7) . In Fig. 7 , nuclei with blue uorescence and f-actin with green uores-cence can be clearly seen in the images, indicating the successful staining of the nuclei with DAPI and the f-actin with FITC labeled phalloidine. Aer 2 h incubation, no red uores-cence was seen in the group containing the W 18 24 Accumulating evidence conrms that the enrichment of tumor promoting cells in hypoxic regions 25 can protect tumor cells from cytolysis induced by chemotherapy or radiotherapy (RT), 26 and contribute to lethal local recurrence rapidly. On this basis, reversing the hypoxic microenvironment is crucial for achieving an optimal therapeutic outcome. We believe that ROS will be achieved in hypoxic regions during the PTT procedure of our W 18 O 49 @PEG-PCL NPs and this will signicantly enhance the susceptibility of hypoxic cancer cells to radiation.
